These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Hummer M; Kemmler G; Kurz M; Kurzthaler I; Oberbauer H; Fleischhacker WW Am J Psychiatry; 1999 Apr; 156(4):631-3. PubMed ID: 10200746 [TBL] [Abstract][Full Text] [Related]
27. [Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study]. Scatton B; Zarifian E; Bianchetti G; Cuche H; Loo H; Morselli PL Encephale; 1982; 8(1):1-8. PubMed ID: 7094868 [TBL] [Abstract][Full Text] [Related]
28. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays. Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566 [TBL] [Abstract][Full Text] [Related]
29. Fluoxetine augmentation of haloperidol in chronic schizophrenia. Shim JC; Kelly DL; Kim YH; Yoon YR; Park JH; Shin JG; Conley RR J Clin Psychopharmacol; 2003 Oct; 23(5):520-2. PubMed ID: 14520132 [No Abstract] [Full Text] [Related]
30. Blood levels of haloperidol in schizophrenic patients. Shvartsburd A; Dekirmenjian H; Smith RC J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528 [TBL] [Abstract][Full Text] [Related]
31. Haloperidol dose, plasma levels, and clinical response: a double-blind study [proceedings]. Ericksen SE; Hurt SW; Chang S Psychopharmacol Bull; 1978 Apr; 14(2):15-6. PubMed ID: 349597 [No Abstract] [Full Text] [Related]
32. Haloperidol plasma levels and dose optimization. Coryell W; Miller DD; Perry PJ Am J Psychiatry; 1998 Jan; 155(1):48-53. PubMed ID: 9433338 [TBL] [Abstract][Full Text] [Related]
33. Lithium and haloperidol. Nemes ZC; Volavka J; Cooper TB; O'Donnell J; Jaeger J Biol Psychiatry; 1986 May; 21(5-6):568-9. PubMed ID: 3697447 [No Abstract] [Full Text] [Related]
34. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report. Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368 [TBL] [Abstract][Full Text] [Related]
35. The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia. Ulrich S; Wurthmann C; Brosz M; Meyer FP Clin Pharmacokinet; 1998 Mar; 34(3):227-63. PubMed ID: 9533984 [TBL] [Abstract][Full Text] [Related]
36. Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia. Rao VA; Bishop M; Coppen A Br J Psychiatry; 1980 Dec; 137():518-21. PubMed ID: 7214106 [TBL] [Abstract][Full Text] [Related]
37. Pimozide versus Haloperidol in acute schizophrenia. A double blind controlled study. Haas S; Beckmann H Pharmacopsychiatria; 1982 Mar; 15(2):70-4. PubMed ID: 7043498 [TBL] [Abstract][Full Text] [Related]
38. Haloperidol plasma levels and clinical response: a therapeutic window relationship. Van Putten T; Marder SR; Mintz J; Poland RE Am J Psychiatry; 1992 Apr; 149(4):500-5. PubMed ID: 1554036 [TBL] [Abstract][Full Text] [Related]
39. Clinical response and serum neuroleptic levels in childhood schizophrenia. Meyers B; Tune LE; Coyle JT Am J Psychiatry; 1980 Apr; 137(4):483-4. PubMed ID: 7361939 [No Abstract] [Full Text] [Related]